Intensity Therapeutics, Inc. (INTS) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Next earnings call: 2026-08-11 (Q2 2026) — full calendar

Earnings Reports

Intensity Therapeutics (INTS) Q2 2026: $30M Capital Need to Scale Phase 3 Sarcoma Trial Amid Encouraging Breast Cancer Data
August 11, 2026

Browse all companies